By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Wellcome Trust announced yesterday that its board has approved the creation of a new business to invest in emerging technologies in the healthcare and life sciences sector.

The new business, called Project Sigma for now, will have an initial investment of £200 million ($317 million), drawn from Wellcome Trust's endowment. A name and brand identity will be announced shortly, Wellcome Trust said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.